Trademark Overview
On Thursday, November 21, 2024, a trademark application was filed for ANKTESIS with the United States Patent and Trademark Office. The USPTO has given the ANKTESIS trademark a serial number of 98865900. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 21, 2024. This trademark is owned by ImmunityBio, Inc.. The ANKTESIS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Cell preparations for medical use in cell therapy for the treatment and prevention of oncologic diseases and disorders, immune-oncologic diseases and disorders, cancer, non-cancerous neoplasia, immunologic dysfunction, immunologic-related diseases, infections, and infectious diseases
Medical services; medical information; providing a website featuring medical information in the fields of immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases; providing medical information relating to immunotherapy, oncology, cancer, immune-oncology, autoimmune diseases, infectious diseases and human diseases